JF
DFTX

Jump Financial’s Definium Therapeutics DFTX Stock Holding History

Jump Financial’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$332K Buy
+7,064
New +$175K ﹤0.01% 1640
2024
Q1 		– Sell
-36,826
Closed -$135K – 2145
2023
Q4 		$135K Buy
36,826
+2,826
+8% +$8.51K ﹤0.01% 1629
2023
Q3 		$106K Buy
+34,000
New +$140K ﹤0.01% 1669

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Jump Financial's DFTX Position: Q2 2026 in Review

Jump Financial opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 7,064 shares worth $332K. The stake represents ﹤0.01% of the portfolio and ranks #1640 among its holdings. This is a return to the name: Jump Financial previously reported a position in DFTX as recently as Q4 2023.

Jump Financial first reported a position in DFTX in Q3 2023 and has held it in 3 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Jump Financial held 7,064 shares of Definium Therapeutics worth $332K as of Q2 2026.
  • Definium Therapeutics was a new Jump Financial position in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1640 holding.
  • Jump Financial first reported a position in Definium Therapeutics in Q3 2023 and has held it in 3 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.